Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.

CONCLUSIONS: The PRS aggregating the FDG-PET/CT SUVmax, total tumor size, and histologic group predicts the prognosis of pStage I lung adenocarcinoma. PMID: 32130543 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32130543?dopt=Abstract

Source: Clinical Lung Cancer - March 3, 2020 Category: Cancer & Oncology Authors: Kawakita N, Toba H, Kawakami Y, Takizawa H, Bando Y, Otuska H, Matsumoto D, Takashima M, Tsuboi M, Yoshida M, Kondo K, Tangoku A Tags: Int J Clin Oncol Source Type: research